Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
13 08 2019
Historique:
received: 26 11 2018
accepted: 23 07 2019
entrez: 15 8 2019
pubmed: 15 8 2019
medline: 7 1 2020
Statut: epublish

Résumé

Antivenoms are fundamental in the therapy for snakebites. In elapid venoms, there are toxins, e.g. short-chain α-neurotoxins, which are quite abundant, highly toxic, and consequently play a major role in envenomation processes. The core problem is that such α-neurotoxins are weakly immunogenic, and many current elapid antivenoms show low reactivity towards them. We have previously developed a recombinant consensus short-chain α-neurotoxin (ScNtx) based on sequences from the most lethal elapid venoms from America, Africa, Asia, and Oceania. Here we report that an antivenom generated by immunizing horses with ScNtx can successfully neutralize the lethality of pure recombinant and native short-chain α-neurotoxins, as well as whole neurotoxic elapid venoms from diverse genera such as Micrurus, Dendroaspis, Naja, Walterinnesia, Ophiophagus and Hydrophis. These results provide a proof-of-principle for using recombinant proteins with rationally designed consensus sequences as universal immunogens for developing next-generation antivenoms with higher effectiveness and broader neutralizing capacity.

Identifiants

pubmed: 31409779
doi: 10.1038/s41467-019-11639-2
pii: 10.1038/s41467-019-11639-2
pmc: PMC6692343
doi:

Substances chimiques

Antibodies 0
Elapid Venoms 0
Neurotoxins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3642

Références

Toxicon. 1982;20(1):95-103
pubmed: 6177061
Int J Health Policy Manag. 2015 Apr 04;4(7):447-57
pubmed: 26188809
Toxicon. 1985;23(1):135-44
pubmed: 3992596
Biochimie. 2018 Apr;147:114-121
pubmed: 29391193
Toxicon. 2010 Jun 15;55(7):1387-95
pubmed: 20193704
J Biol Chem. 2016 Feb 5;291(6):2616-29
pubmed: 26680001
J Proteomics. 2016 Apr 14;138:83-94
pubmed: 26924299
Toxicon. 1994 Mar;32(3):351-63
pubmed: 8016856
Toxins (Basel). 2014 May 13;6(5):1526-58
pubmed: 24828754
Peptides. 2017 Feb;88:80-86
pubmed: 28010961
Toxins (Basel). 2016 Oct 18;8(10):
pubmed: 27763543
Toxins (Basel). 2014 Dec 15;6(12):3388-405
pubmed: 25517863
Toxins (Basel). 2017 Apr 19;9(4):
pubmed: 28422078
Toxicon. 2011 Jun;57(7-8):1073-80
pubmed: 21549143
Toxicon. 2015 Jan;93:61-7
pubmed: 25447773
J Proteomics. 2014 Jun 13;105:295-306
pubmed: 24613619
Sci Rep. 2016 Nov 08;6:36629
pubmed: 27824133
J Proteomics. 2017 Mar 6;156:29-39
pubmed: 28062377
J Toxicol Clin Toxicol. 2004;42(2):171-8
pubmed: 15214622
Toxicon. 2013 May;66:47-58
pubmed: 23416229
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20651-6
pubmed: 24297900
Toxicon. 2018 Dec 1;155:32-37
pubmed: 30315836
Biol Aujourdhui. 2010;204(1):87-91
pubmed: 20950580
Toxicon. 1998 Jan;36(1):93-114
pubmed: 9604285
Toxicon. 2008 Dec 15;52(8):881-8
pubmed: 18926842
Toxicon. 2016 Nov;122:7-25
pubmed: 27641749
J Proteomics. 2014 Jan 16;96:240-52
pubmed: 24269350
J Proteomics. 2017 Jan 6;150:98-108
pubmed: 27593527
Biochim Biophys Acta. 1974 Aug 8;359(2):222-32
pubmed: 4850498
Cell Mol Life Sci. 2018 Dec;75(23):4465-4478
pubmed: 30069700
J Biochem. 1995 Oct;118(4):686-92
pubmed: 8576079
Toxicon. 2017 Nov;138:151-158
pubmed: 28867663
Proteomics. 2008 May;8(9):1919-32
pubmed: 18384102
Int Immunopharmacol. 2014 Jul;21(1):148-55
pubmed: 24815989
J Proteomics. 2015 Apr 24;119:126-42
pubmed: 25688917
Biochimie. 2014 Aug;103:109-17
pubmed: 24793485
J Proteomics. 2016 Sep 2;146:148-64
pubmed: 27318176
J Proteomics. 2014 May 30;103:137-52
pubmed: 24704853
PLoS One. 2012;7(6):e39166
pubmed: 22720062
WHO Offset Publ. 1981;(58):1-44
pubmed: 7245916
Inflamm Allergy Drug Targets. 2011 Oct;10(5):369-80
pubmed: 21745181
J Venom Anim Toxins Incl Trop Dis. 2016 Sep 09;22(1):25
pubmed: 27617022
PLoS Med. 2008 Nov 4;5(11):e218
pubmed: 18986210
Toxicon. 1991;29(11):1279-303
pubmed: 1814005
PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2302
pubmed: 24130909
Toxins (Basel). 2017 Sep 18;9(9):
pubmed: 28927001
Toxicon. 2007 Jan;49(1):8-18
pubmed: 17097125
Toxicon. 2015 Sep 15;104:43-5
pubmed: 26238171
Amino Acids. 2018 Jul;50(7):885-895
pubmed: 29626299
Toxicon. 2011 Nov;58(6-7):455-63
pubmed: 21906611
J Proteome Res. 2011 Apr 1;10(4):1816-27
pubmed: 21280576
J Proteome Res. 2011 Mar 4;10(3):1266-80
pubmed: 21171584
Biochem J. 1978 Nov 1;175(2):507-17
pubmed: 743209
Toxicon. 1994 Dec;32(12):1657-65
pubmed: 7725333

Auteurs

Guillermo de la Rosa (G)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico. guillermo.delarosa.h@gmail.com.
The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, M5S3E1, Canada. guillermo.delarosa.h@gmail.com.

Felipe Olvera (F)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico.

Irving G Archundia (IG)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico.

Bruno Lomonte (B)

Instituto Clodomiro Picado, Universidad de Costa Rica, San José, 11501, Costa Rica.

Alejandro Alagón (A)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico.

Gerardo Corzo (G)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico. corzo@ibt.unam.mx.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH